Furthermore, we demonstrated that NUPR1 depletion led to a significant reversal of the resistance to sorafenib in ccRCC, which involved the downregulation of stemness-associated genes, including Nanog, CD44, Sox2 and Oct-4. The gene discussed is SOX2; the disease is nonpapillary renal cell carcinoma.